Protective effects of nattokinase against microvasculopathy and neuroinflammation in diabetic retinopathy
Journal of Diabetes · 2023
DOI: 10.1111/1753-0407.13439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes, 2023. Verfasst von Zijing Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus, Experimental, Subtilisins, Neuroinflammatory Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Special Support Plan for High-Level Talents in Guangdong Province for Young Top Talents in Science and Technology Innovation.
Abstract (Originalsprache)
Aims
Diabetic retinopathy (DR) is a significant global public health concern. Alternative, safe, and cost‐effective pharmacologic approaches are warranted. We aimed to investigate the therapeutic potential of nattokinase (NK) for early DR and the underlying molecular mechanism.
Methods
A mouse model of diabetes induced by streptozotocin was utilized and NK was administered via intravitreal injection. Microvascular abnormities were evaluated by examining the leakage from blood–retinal barrier dysfunction and loss of pericytes. Retinal neuroinflammation was examined through the assessment of glial activation and leukostasis. The level of high mobility group box 1 (HMGB1) and its downstream signaling molecules was evaluated following NK treatment.
Results
NK administration significantly improved the blood–retinal barrier function and rescued pericyte loss in the diabetic retinas. Additionally, NK treatment inhibited diabetes‐induced gliosis and inflammatory response and protected retinal neurons from diabetes‐induced injury. NK also improved high glucose‐induced dysfunction in cultured human retinal micrangium endothelial cells. Mechanistically, NK regulated diabetes‐induced inflammation partially by modulating HMGB1 signaling in the activated microglia.
Conclusions
This study demonstrated the protective effects of NK against microvascular damages and neuroinflammation in the streptozotocin‐induced DR model, suggesting that NK could be a potential pharmaceutical agent for the treatment of DR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, China.
- Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China.
- Shantou University Medical College, Shantou, China.
ORCID-Profile: Zijing Huang, Tsz Kin Ng, Chong-Bo Chen
Förderung
- National Natural Science Foundation of China
- Special Support Plan for High-Level Talents in Guangdong Province for Young Top Talents in Science and Technology Innovation
Zitieren
APA
Huang, Z., Chu, W. K., Ng, T. K., Chen, S., Liang, J., Chen, C. B., Xu, Y., Xie, B., Ke, S., Liu, Q., Chen, W., & Huang, D. (2023). Protective effects of nattokinase against microvasculopathy and neuroinflammation in diabetic retinopathy. Journal of Diabetes. https://doi.org/10.1111/1753-0407.13439
Vancouver
Huang Z, Chu WK, Ng TK, Chen S, Liang J, Chen CB, et al. Protective effects of nattokinase against microvasculopathy and neuroinflammation in diabetic retinopathy. Journal of Diabetes. 2023. doi:10.1111/1753-0407.13439
BibTeX
@article{Huang2023,
author = {Huang, Zijing and Chu, Wai Kit and Ng, Tsz Kin and Chen, Shaolang and Liang, Jiajian and Chen, Chong-Bo and Xu, Yanxuan and Xie, Biyao and Ke, Shuping and Liu, Qingping and Chen, Weiqi and Huang, Dingguo},
title = {Protective effects of nattokinase against microvasculopathy and neuroinflammation in diabetic retinopathy},
journal = {Journal of Diabetes},
year = {2023},
doi = {10.1111/1753-0407.13439}
}
EUVIMED